Maxime Tapponnier

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial

Juan F. Iglesias, Olivier Müller, Dik Heg et al. · The Lancet · 2019 · 182 citations · Full text

Percutaneous Coronary Intervention, Cardiovascular Disease, Atherosclerosis +7

Functional Identification of the Alveolar Edema Reabsorption Activity of Murine Tumor Necrosis Factor-α

Nadia Elia, Maxime Tapponnier, Michael A. Matthay et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 67 citations

Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI

Thomas Pilgrim, Olivier Müller, Dik Heg et al. · JACC: Cardiovascular Interventions · 2021 · 55 citations · Full text

Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial

Juan F. Iglesias, Marco Roffi, Sylvain Losdat et al. · The Lancet · 2023 · 37 citations

Superiority Trial, Cardiovascular Disease, Long-term Outcomes +7

Time course of lung injury in rat acute pancreatitis

Denis R. Morel, Jean‐Louis Frossard, Banu Cikirikcioglu et al. · Intensive Care Medicine · 2006 · 18 citations

Acute Lung Injury, Rat Acute Pancreatitis, Pancreatic Fluid Collection +4